Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

OptimizeRx (OPRX) Return on Sales (2016 - 2025)

Historic Return on Sales for OptimizeRx (OPRX) over the last 17 years, with Q3 2025 value amounting to 0.03%.

  • OptimizeRx's Return on Sales rose 4600.0% to 0.03% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.04%, marking a year-over-year increase of 4000.0%. This contributed to the annual value of 0.17% for FY2024, which is 800.0% up from last year.
  • As of Q3 2025, OptimizeRx's Return on Sales stood at 0.03%, which was up 4600.0% from 0.05% recorded in Q2 2025.
  • OptimizeRx's 5-year Return on Sales high stood at 0.15% for Q4 2024, and its period low was 0.49% during Q1 2023.
  • Moreover, its 5-year median value for Return on Sales was 0.18% (2023), whereas its average is 0.16%.
  • As far as peak fluctuations go, OptimizeRx's Return on Sales tumbled by -4000bps in 2023, and later skyrocketed by 5600bps in 2024.
  • Over the past 5 years, OptimizeRx's Return on Sales (Quarter) stood at 0.03% in 2021, then plummeted by -154bps to 0.02% in 2022, then plummeted by -2396bps to 0.41% in 2023, then skyrocketed by 135bps to 0.15% in 2024, then crashed by -80bps to 0.03% in 2025.
  • Its last three reported values are 0.03% in Q3 2025, 0.05% for Q2 2025, and 0.1% during Q1 2025.